The Push for Generics Challenges Manufacturers

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-07-02-2003, Volume 27, Issue 7

Biotech firms face new issues as FDA weighs policies to streamline generic-drug approvals and reduce patent disputes.

Related Content:

Quality SystemsRegulatory WatchGeneric DrugsDosage FormsPharmaceutical Technology-07-02-2003
Safeguarding Biologics—Blending Engineering Ingenuity and Managerial Excellence
Convergence in the Global Regulatory Village